According to Zhitong Finance App, Baiyunshan (00874.HK) announced that Guangzhou Pharmaceutical Baiyunshan Hong Kong Co., Ltd. (“Baiyunshan Hong Kong”), a wholly-owned subsidiary of the company, plans to invest HK$350 million to pledge the limited partnership share of the Walbo Capital Health Limited Partnership Fund (“Asia Health Fund”), accounting for 35% of the fund after the fundraising is completed.

Zhitongcaijing · 4d ago
According to Zhitong Finance App, Baiyunshan (00874.HK) announced that Guangzhou Pharmaceutical Baiyunshan Hong Kong Co., Ltd. (“Baiyunshan Hong Kong”), a wholly-owned subsidiary of the company, plans to invest HK$350 million to pledge the limited partnership share of the Walbo Capital Health Limited Partnership Fund (“Asia Health Fund”), accounting for 35% of the fund after the fundraising is completed.